Characterisation of immune responses in healthy foals when a multivalent vaccine protocol was initiated at age 90 or 180 days

Equine Vet J. 2015 Nov;47(6):667-74. doi: 10.1111/evj.12350. Epub 2014 Dec 30.

Abstract

Reasons for performing study: Protection from infectious disease requires antigen-specific immunity. In foals, most vaccine protocols are delayed until 6 months to avoid maternal antibody interference. Susceptibility to disease may exist prior to administration of vaccination at age 4-6 months.

Objectives: The aim of this investigation was to characterise immune activation among healthy foals in response to a multivalent vaccine protocol and compare immune responses when foals were vaccinated at age either 90 or 180 days.

Study design: Randomised block design.

Methods: Twelve healthy foals with colostral transfer were blocked for age and randomly assigned to vaccination at age 90 days (treatment) or at age 180 days (control). Vaccination protocols included a 3-dose series and booster vaccine administered at age 11 months.

Results: Immune response following vaccination at age 90 or 180 days was comparable for several measures of cellular immunity. Antigen specific CD4+ and CD8+ expression of interleukin-4, interferon-γ and granzyme B to eastern equine encephalomyelitis, western equine encephalomyelitis, West Nile virus, tetanus toxoid, equine influenza and equine herpesvirus-1/4 antigens were evident for both groups 30 days after initial vaccine and at age 344 days. Both groups showed a significant increase in antigen-specific immunoglobulin G expression following booster vaccine at age 11 months, thereby indicating memory immune responses.

Conclusions: The data presented in this report demonstrate that young foals are capable of immune activation following a 3-dose series with a multivalent vaccine, despite presence of maternal antibodies. Although immune activation does not automatically confer protection, several of the immune indicators measured showed comparable expression in foals vaccinated at 3 months relative to control foals vaccinated at age 6 months. In high-risk situations where immunity may be required earlier than following a conventional vaccine series, our data provide evidence that foals respond to immunisation initiated at 3 months in a comparable manner to foals initiated at an older age.

Keywords: foal; horse; immunity; vaccine.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging
  • Animals
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • Antigens, Viral / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / metabolism
  • Gene Expression Regulation / immunology
  • Genes, MHC Class II / immunology
  • Granzymes / genetics
  • Granzymes / metabolism
  • Horse Diseases / prevention & control*
  • Horses
  • Immunization Schedule*
  • Interferon-gamma / genetics
  • Interferon-gamma / metabolism
  • Interleukin-4 / genetics
  • Interleukin-4 / metabolism
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / immunology*
  • Virus Diseases / prevention & control
  • Virus Diseases / veterinary*

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Viral Vaccines
  • Interleukin-4
  • Interferon-gamma
  • Granzymes